MediPoint: Viscosupplementation-Europe Analysis and Market Forecasts
Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.
This report focuses on the market outlook for viscosupplementation products in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.
Key Questions Answered
What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the European market?
Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?
What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?
What are the challenges and complications that have hindered widespread adoption?
With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?
Overview of recent key industry events and analysis of their market impact.
Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.
Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.
Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
Analysis of the current and future market competition in the European viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy
The report will enable you to-
Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.
Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Track device sales in country-specific viscosupplementation markets from 2014-2023.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Table of Contents
1 About the Authors 2
1.1 Analysts 2
1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2
1.1.2 Linda Tian, Managing Analyst, Medical Devices 2
1.1.3 Global Head of Medical Devices 2
2 Table of Contents 3
2.1 List of Tables 5
2.2 List of Figures 5
3 Executive Summary 6
3.1 Overview 6
3.2 Market Dynamics 7
3.3 Key Players in the Viscosupplementation Market 8
3.4 Viscosupplementation Market Future Outlook 8
4 Introduction 9
4.1 Catalyst 9
4.2 Related Reports 9
4.3 Upcoming Related Reports 10
5 Market Outlook 11
5.1 Procedure Trends 11
5.2 Pricing Trends 13
5.3 Revenue Trends 15
5.4 Company Share Analysis 17
6 Market Insights 18
6.1 Europe 18
6.1.1 Denmark, Finland, Norway, and Sweden 19
6.1.2 Belgium, France, and Netherlands 19
6.1.3 Germany and Switzerland 20
6.1.4 UK and Ireland 21
6.1.5 Italy, Portugal, and Spain 22
6.1.6 Austria, Czech Republic, Hungary, and Poland 22
6.1.7 Greece, Russia, and Turkey 22
7 Competitive Assessment 23
7.1 Overview 23
7.2 Anika Therapeutics 23
7.2.1 Overview 23
7.2.2 Portfolio Assessment 24
7.2.3 Competitive Positioning 24
7.3 Ferring Pharmaceuticals 24
7.3.1 Overview 24
7.3.2 Portfolio Assessment 25
7.3.3 Competitive Positioning 25
7.4 Fidia Farmaceutici 25
7.4.1 Overview 25
7.4.2 Portfolio Assessment 25
7.4.3 Competitive Positioning 26
7.5 Meda AB (Mylan) 27
7.5.1 Overview 27
7.5.2 Portfolio Assessment 27
7.5.3 News and Deals Analysis 27
7.5.4 Competitive Positioning 27
7.6 Sanofi 28
7.6.1 Overview 28
7.6.2 Portfolio Assessment 28
7.6.3 Competitive Positioning 28
7.7 Other Players 29
8 Appendix 31
8.1 Bibliography 31
8.2 Abbreviations 31
8.3 Methodology 32
8.3.1 Overview 32
8.3.2 Coverage 32
8.3.3 Secondary Research 32
8.3.4 Forecasting Methodology 33
8.3.5 Primary Research Summary 34
8.4 About MediPoint 35
8.5 About GlobalData 35
8.6 Contact Us 35
8.7 Disclaimer 36
List of Figures
Figure 1: Viscosupplementation Sales for Europe, by Country, 2016 and 2023 7
List of Tables
Table 1: Key Metrics in the Europe Viscosupplementation Market 6
Table 2: Europe Viscosupplementation Volume Forecast, 2014-2023 11
Table 3: Europe Viscosupplementation Average Selling Price Forecast ($), 2014-2023 13
Table 4: Europe Viscosupplementation Market Revenue Forecast ($M), 2014-2023 15
Table 5: Europe Viscosupplementation Company Share Analysis, 2016 17
Table 6: Anika Therapeutics-Key Marketed Products Assessment 24
Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 25
Table 8: Fidia Farmaceutici-Key Marketed Products Assessment 25
Table 9: Fidia Farmaceutici-Key Clinical Trials 26
Table 10: Meda AB-Key Marketed Products Assessment 27
Table 11: Sanofi-Key Marketed Products Assessment 28
Table 12: Summary of Other Players in the Viscosupplementation Market, 2017 29
Single User License:
Corporate User License:
Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"